60 Degrees Pharmaceuticals, Inc.
SXTP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $614.8K in total; no superinvestor holds it.
Other share classesSXTPW
13F holders, Q3 2024
Institutional positions in 60 Degrees Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- −3 vs. Q2 2024
- Shares held
- 32.9K
- −328.1K (−90.9%) vs. Q2 2024
- Total value
- $41.4K
- −$48.7K (−54.0%) vs. Q2 2024
- New holders
- 3
- 0 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SXTP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $614.8K |
| Q1 2026 | 8 | $340.1K |
| Q4 2025 | 7 | $22.5K |
| Q3 2025 | 7 | $62.9K |
| Q2 2025 | 5 | $36.1K |
| Q1 2025 | 6 | $54.8K |
| Q4 2024 | 9 | $198.0K |
| Q3 2024 | 7 | $41.4K |
| Q2 2024 | 10 | $90.1K |
| Q1 2024 | 8 | $126.6K |
| Q4 2023 | 4 | $467.4K |
| Q3 2023 | 6 | $479.1K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding 60 Degrees Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 12,678 | $16.0K | 0.00% | −32,462−71.9% | Reduced |
| Citadel Advisors LLC | 10,095 | $12.7K | 0.00% | +10,095 | New |
| National Bank of Canada | 4,000 | $5.00K | 0.00% | +4,000 | New |
| UBS Group AG | 3,311 | $4.14K | 0.00% | −31,168−90.4% | Reduced |
| Tower Research Capital LLC (TRC) | 1,473 | $1.84K | 0.00% | −5,622−79.2% | Reduced |
| Safe Harbor Fiduciary, LLC | 1,375 | $1.72K | 0.00% | +1,375 | New |
| Bank of America Corp | 6 | $8 | 0.00% | −50−89.3% | Reduced |
| Central Bank & Trust Co | 0 | $0 | 0.00% | −167,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −38,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,788−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,196−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,303−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |